Keywords
arrhythmia
management
How to Cite
Abstract
Atrial fibrillation is a supraventricular tachyarrhythmia with a significant health impact. It’s the most common sustained arrhythmia and it’s characterized by causing palpitations, alterations on the electrocardiogram and on its patient’s pulse. It is commonly associated with cardiovascular abnormalities and significant morbidity and mortality. The management of rhythm and rate have the same stroke and mortality risk, and it’s still currently being debated which management should be prioritized. It is essential that the cardioembolic risk is assessed, even after restoring sinus rhythm, to determine which patients should be anticoagulated. Direct-acting oral anticoagulants are currently preferred over warfarin for patients with nonvalvular atrial fibrillation. Proper treatment for atrial fibrillation is important in order to reduce symptoms, prevent thromboembolisms, and possible cardiomyopathy.
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The authors keep the copyright and publication rights in the journal the right of the first publication and this possibility to edit, reproduce, distribute, expose and publicly communicate on the magazine's website. Likewise, it assumes the commitment on any litigation or claim related to the rights of intellectual property, exonerating of responsibility to the Science and Health Magazine of the UCIMED. In addition, you can see how they are published in this journal (eg, Include in an institutional repository or publish it in a book) as long as they clearly indicate the work published for the first time in the magazine Science and Health of the UCIMED.